Business & Investment

NAFDAC shuts down non-compliant local pharmaceutical companies

To promote zero tolerance for the distribution of substandard counterfeit medicines in Nigeria, the National Food and Drug Administration (NAFDAC) has closed six local manufacturers of finished medicine FPPs.

Mojisola Adeyeye, Directorate General of NAFDAC, dropped a hint on Monday, December 28, 2020 in a statement released in Abuja. According to Adeyeye, the drug company was closed under national oversight of manufacturing activities.

She said, despite proper notice, these local manufacturers meet the minimum Good Manufacturing Practices (GMP) standards required to ensure the quality, safety, and efficacy of medicines. He said he was disappointed that he did not meet.

However, NAFDAC DG argued that the company remained closed until its respective GMP compliance was met.

She said these current actions act as a deterrent to all domestic and foreign manufacturers who may not want to comply with basic GMP requirements, and a new campaign to remove science fiction medicines from the country. Said to participate in.

NAFDAC has recently blacklisted foreign manufacturers of finished medicines (FPPs) and NAFDAC in its current efforts and constant efforts to address the challenges of substandard and counterfeit (SF) medicines in Nigeria. Excluded local representatives for serious violations of existing laws and regulations.

But Adeyeye said, “NAFDAC bears the pesky responsibility of protecting the health of its people and does not go back to making Nigerians accessible only to safe, effective and high-quality medicines.” Said.

NAFDAC shuts down non-compliant local pharmaceutical companies NAFDAC shuts down non-compliant local pharmaceutical companies

Back to top button